Safeguard Scientifics (NYSE:SFE)‘s stock had its “mkt perform” rating reissued by analysts at Keefe, Bruyette & Woods in a report issued on Wednesday. They currently have a $13.25 target price on the asset manager’s stock. Keefe, Bruyette & Woods’ target price would indicate a potential upside of 11.34% from the company’s current price.

A number of other analysts also recently issued reports on SFE. ValuEngine raised Safeguard Scientifics from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st. Zacks Investment Research raised Safeguard Scientifics from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th.

Safeguard Scientifics (NYSE SFE) traded down $0.10 during mid-day trading on Wednesday, reaching $11.90. The company’s stock had a trading volume of 36,800 shares, compared to its average volume of 64,688. The company has a debt-to-equity ratio of 0.45, a quick ratio of 1.03 and a current ratio of 1.03. Safeguard Scientifics has a 52-week low of $10.65 and a 52-week high of $14.40.

Safeguard Scientifics (NYSE:SFE) last posted its earnings results on Thursday, October 26th. The asset manager reported ($0.91) earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of ($1.11) by $0.20. During the same period in the prior year, the business earned ($1.18) EPS. analysts predict that Safeguard Scientifics will post -4.47 earnings per share for the current year.

A number of hedge funds and other institutional investors have recently made changes to their positions in SFE. Vanguard Group Inc. increased its position in Safeguard Scientifics by 1.9% during the first quarter. Vanguard Group Inc. now owns 828,897 shares of the asset manager’s stock worth $10,528,000 after buying an additional 15,086 shares during the last quarter. Geode Capital Management LLC boosted its holdings in shares of Safeguard Scientifics by 4.8% during the first quarter. Geode Capital Management LLC now owns 146,721 shares of the asset manager’s stock worth $1,863,000 after acquiring an additional 6,742 shares during the period. Schwab Charles Investment Management Inc. boosted its holdings in shares of Safeguard Scientifics by 6.3% during the first quarter. Schwab Charles Investment Management Inc. now owns 86,757 shares of the asset manager’s stock worth $1,102,000 after acquiring an additional 5,130 shares during the period. Bank of America Corp DE boosted its holdings in shares of Safeguard Scientifics by 8.2% during the first quarter. Bank of America Corp DE now owns 25,289 shares of the asset manager’s stock worth $321,000 after acquiring an additional 1,907 shares during the period. Finally, Goldman Sachs Group Inc. boosted its holdings in shares of Safeguard Scientifics by 12.9% during the first quarter. Goldman Sachs Group Inc. now owns 15,336 shares of the asset manager’s stock worth $195,000 after acquiring an additional 1,754 shares during the period. 76.29% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece of content was originally posted by American Banking News and is the sole property of of American Banking News. If you are reading this piece of content on another domain, it was stolen and republished in violation of United States & international trademark & copyright law. The legal version of this piece of content can be read at https://www.americanbankingnews.com/2017/12/06/safeguard-scientifics-sfe-given-hold-rating-at-keefe-bruyette-woods.html.

Safeguard Scientifics Company Profile

Safeguard Scientifics, Inc is engaged in providing capital to technology companies within the fields of healthcare, financial services and digital media. The Company holds interest in companies, which it refers to as partner companies. As of December 31, 2016, the Company held interests in 29 non-consolidated partner companies.

Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.